APOA5 Produits
(Apolipoprotein A-V (APOA5))
Catégories
The protein encoded by this gene is an apolipoprotein that plays an important role in regulating the plasma triglyceride levels, a major risk factor for coronary artery disease. It is a component of high density lipoprotein and is highly similar to a rat protein that is upregulated in response to liver injury. Mutations in this gene have been associated with hypertriglyceridemia and hyperlipoproteinemia type 5. This gene is located proximal to the apolipoprotein gene cluster on chromosome 11q23. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Oct 2009].
antibodies-online.com est synonyme de produits de recherche de haute qualité. Cherchez, trouvez et commandez des outils avec des données de validation étendues, des images, des références. Notre service clientèle scientifique est toujours à votre disposition si vous avez des questions sur la sélection ou l'application de nos produits.
Catégories APOA5 en vedette
APOA5 Anticorps
High quality antibodies with extensive validation data.
APOA5 Kits ELISA
Reliable ELISA kits for a wide range of species.
APOA5 Protéines
Proteins for various applications incl. WB, ELISA, IF etc.
APOA5 recommandé Anticorps
Produit
Reactivity
Application
Validations
N° du produit
Quantité
Fiche technique
Reactivity
Human
Application
WB, IHC, IP, ICC
Validations
- (5)
N° du produit
ABIN7434506
Quantité
100 μL
Fiche technique
Fiche technique
Reactivity
Human
Application
WB, IHC, IP, ICC
Validations
- (5)
N° du produit
ABIN7427942
Quantité
100 μL
Fiche technique
Fiche technique
Reactivity
Mouse
Application
WB, IHC, IP, ICC
Validations
- (3)
N° du produit
ABIN7438598
Quantité
100 μL
Fiche technique
Fiche technique
APOA5 recommandé Kits ELISA
Produit
Reactivity
Analytical Method
Validations
N° du produit
Quantité
Fiche technique
Reactivity
Human
Analytical Method
Quantitative Competition ELISA
Validations
- (4)
- (1)
N° du produit
ABIN6973943
Quantité
96 tests
Fiche technique
Fiche technique
Reactivity
Human
Analytical Method
Quantitative Sandwich ELISA
Validations
- (1)
N° du produit
ABIN6963557
Quantité
96 tests
Fiche technique
Fiche technique
Reactivity
Mouse
Analytical Method
Quantitative Sandwich ELISA
Validations
- (1)
N° du produit
ABIN6999564
Quantité
96 tests
Fiche technique
Fiche technique
APOA5 recommandé Protéines
Produit
Reactivity
Source
Validations
N° du produit
Quantité
Fiche technique
Reactivity
Human
Source
Wheat germ
Validations
- (1)
- (1)
N° du produit
ABIN1345336
Quantité
10 μg
Fiche technique
Fiche technique
Reactivity
Mouse
Source
Escherichia coli (E. coli)
Validations
- (1)
N° du produit
ABIN7273849
Quantité
100 μg
Fiche technique
Fiche technique
Reactivity
Human
Source
Escherichia coli (E. coli)
Validations
- (1)
N° du produit
ABIN5853437
Quantité
50 μg
Fiche technique
Fiche technique
Dernières publications sur nos produits APOA5
: "Apolipoprotein CIII and Angiopoietin-like Protein 8 are Elevated in Lipodystrophy and Decrease after Metreleptin." dans: Journal of the Endocrine Society, Vol. 5, Issue 2, pp. bvaa191, (2021) (PubMed).: "Susceptibility loci for metabolic syndrome and metabolic components identified in Han Chinese: a multi-stage genome-wide association study." dans: Journal of cellular and molecular medicine, Vol. 21, Issue 6, pp. 1106-1116, (2018) (PubMed).
: "Apolipoprotein A5 regulates intracellular triglyceride metabolism in adipocytes." dans: Molecular medicine reports, Vol. 16, Issue 5, pp. 6771-6779, (2018) (PubMed).
: "A promoter variant of the APOA5 gene increases atherogenic LDL levels and arterial stiffness in hypertriglyceridemic patients." dans: PLoS ONE, Vol. 12, Issue 12, pp. e0186693, (2018) (PubMed).
: "Apolipoprotein A-V is not a major determinant of triglyceride levels during human sepsis." dans: Journal of critical care, Vol. 30, Issue 4, pp. 727-31, (2015) (PubMed).
: "Apolipoprotein A5 deficiency aggravates high-fat diet-induced obesity due to impaired central regulation of food intake." dans: FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 27, Issue 8, pp. 3354-62, (2013) (PubMed).
: "APOA5 gene expression in the human intestinal tissue and its response to in vitro exposure to fatty acid and fibrate." dans: Nutrition, metabolism, and cardiovascular diseases : NMCD, Vol. 22, Issue 9, pp. 756-62, (2012) (PubMed).
: "APOA5 Ala315>Val, identified in patients with severe hypertriglyceridemia, is a common mutation with no major effects on plasma lipid levels." dans: Clinical chemistry and laboratory medicine : CCLM / FESCC, Vol. 46, Issue 6, pp. 773-7, (2008) (PubMed).
: "Effects of six APOA5 variants, identified in patients with severe hypertriglyceridemia, on in vitro lipoprotein lipase activity and receptor binding. ..." dans: Arteriosclerosis, thrombosis, and vascular biology, Vol. 28, Issue 10, pp. 1866-71, (2008) (PubMed).
: "APOA5 gene variation modulates the effects of dietary fat intake on body mass index and obesity risk in the Framingham Heart Study." dans: Journal of molecular medicine (Berlin, Germany), Vol. 85, Issue 2, pp. 119-28, (2007) (PubMed).
Synonymes et noms alternatifs relatifs à APOA5
apolipoprotein A5 (APOA5), apolipoprotein A-V (Apoa5), apolipoprotein A5 (Apoa5), apolipoprotein A5 L homeolog (apoa5.L), apolipoprotein A5 (apoa5), 1300007O05Rik, apo-AV, apoA-V, apoa-v, APOA5, APOAV, Apoav, apoav, MGC140487, RAP3, rap3Protein level used designations for APOA5
- apo-AV
- apolipoprotein A5
- regeneration-associated protein 3
- apoA-V
- apolipoprotein AV
- apolipoprotein A-V
Vous êtes ici:
